These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18323763)

  • 21. Chronic delusional hallucinatory psychosis in early-onset Parkinson's disease: drug-induced complication or sign of an idiopathic psychiatric illness?
    Cannas A; Spissu A; Floris GL; Saddi MV; Cossu G; Melis M; Tacconi P; Milia A; Mascia MM; Giagheddu M
    Neurol Sci; 2001 Feb; 22(1):53-4. PubMed ID: 11487198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions.
    Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):34-5. PubMed ID: 18323765
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychosis in Parkinson's Disease: A Lesson from Genetics.
    Angelopoulou E; Bougea A; Papageorgiou SG; Villa C
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions.
    Umemura A; Oka Y; Okita K; Matsukawa N; Yamada K
    J Neurosurg; 2011 Jun; 114(6):1701-5. PubMed ID: 21375379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.
    Friedman JH; Agarwal P; Alcalay R; Black KJ; Chou KL; Cote L; Dayalu P; Frank S; Hartlein J; Hauser RA; Lang AE; Marsh L; Marshall F; Moskowitz C; Ravina B; Riley D; Sanchez-Ramos J; Simon DK; Simuni T; Sutton J; Tuite P; Weintraub D; Zesiewicz T
    Int J Neurosci; 2011 Aug; 121(8):472-6. PubMed ID: 21663381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scales to evaluate psychosis in Parkinson's disease.
    Goetz CG
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S38-41. PubMed ID: 20083004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Weintraub D; Hurtig HI
    Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of Cannabis on hallucinations in Parkinson's disease patients.
    Cravanas B; Frei K
    J Neurol Sci; 2020 Dec; 419():117206. PubMed ID: 33161300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.
    Barrett MJ; Smolkin ME; Flanigan JL; Shah BB; Harrison MB; Sperling SA
    Parkinsonism Relat Disord; 2017 Oct; 43():56-60. PubMed ID: 28735797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real or imagined: We need a new scale for psychosis in Parkinson's disease.
    Pontone GM; Mills KA; Dobkin RD; Hinkle JT; Nirenberg MJ; Schneider RB;
    Parkinsonism Relat Disord; 2024 Apr; 121():106004. PubMed ID: 38278654
    [No Abstract]   [Full Text] [Related]  

  • 33. The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
    Fénelon G; Soulas T; Zenasni F; Cleret de Langavant L
    Mov Disord; 2010 Apr; 25(6):763-6. PubMed ID: 20437542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features.
    Schutte MJL; Linszen MMJ; Marschall TM; Ffytche DH; Koops S; van Dellen E; Heringa SM; Slooter AJC; Teunisse R; van den Heuvel OA; Lemstra AW; Foncke EMJ; Slotema CW; de Jong J; Rossell SL; Sommer IEC
    Psychiatry Res; 2020 Oct; 292():113314. PubMed ID: 32731082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.
    Kiziltan G; Ozekmekçi S; Ertan S; Ertan T; Erginöz E
    J Neurol; 2007 Apr; 254(4):448-52. PubMed ID: 17401525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
    Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
    Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evidence-based treatment of psychosis associated with Parkinson's disease].
    Haussmann R; Bauer M; Donix M
    Nervenarzt; 2016 May; 87(5):543-51. PubMed ID: 26643499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychiatric and cognitive symptoms in Parkinson disease].
    Aarsland D; Pedersen KF; Ehrt U; Bronnick K; Gjerstad MD; Larsen JP
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2072-6. PubMed ID: 18846124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.
    Aarsland D; Litvan I; Larsen JP
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):42-9. PubMed ID: 11207328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.